Gerresheimer AG (GXI) Receives Average Rating of “Hold” from Analysts

Shares of Gerresheimer AG (ETR:GXI) have earned a consensus rating of “Hold” from the twelve brokerages that are currently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is €69.17 ($80.43).

A number of equities research analysts recently issued reports on GXI shares. Kepler Capital Markets set a €62.00 ($72.09) target price on shares of Gerresheimer and gave the company a “sell” rating in a report on Thursday, April 11th. Goldman Sachs Group set a €65.00 ($75.58) target price on shares of Gerresheimer and gave the company a “neutral” rating in a report on Monday, February 11th. Independent Research set a €72.00 ($83.72) target price on shares of Gerresheimer and gave the company a “neutral” rating in a report on Friday, April 12th. Hauck & Aufhaeuser set a €50.00 ($58.14) target price on shares of Gerresheimer and gave the company a “sell” rating in a report on Monday, March 25th. Finally, JPMorgan Chase & Co. set a €49.50 ($57.56) target price on shares of Gerresheimer and gave the company a “sell” rating in a report on Monday, January 21st.

Gerresheimer stock opened at €66.00 ($76.74) on Thursday. Gerresheimer has a 1 year low of €51.10 ($59.42) and a 1 year high of €80.25 ($93.31). The company has a market capitalization of $2.07 billion and a P/E ratio of 16.07. The company has a quick ratio of 0.51, a current ratio of 0.74 and a debt-to-equity ratio of 108.42.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Read More: Marijuana Stocks Future Looks Bright

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit